The mucin gene, Muc1 is expressed in glandular epithelial cells and is involved in lubricative and protective functions. It is also overexpressed in many carcinomas including breast and lung cancer cells. To study the transcriptional regulation of Muc1, a 2.4 kb fragment containing the promoter region of the hamster Muc1 gene was cloned and analyzed for its ability to mediate transcription. Transcriptional initiation was localized to 22 base pairs downstream of the TATA box. Functional analysis of the Muc1 promoter was performed in hamster (HP-1 and CHO) and human cells (MCF-7, A549 and BEAS-2B) using deletion/reporter constructs. A positive regulatory region between bases -555 and -252 and a putative negative regulatory region (P-NRE) between nucleotides -1652 and -1614 were found to be active in transfected cells. The P-NRE contains a YY1 transcription factor binding site and electrophoretic mobility shift assays with HP-1 cell nuclear extract revealed the binding of YY1 to this site. Our data suggests that YY1 may play an inhibitory role in the transcription of the Muc1 gene.
INTRODUCTION
The gene encoding the transmembrane glycoprotein MUC1 was first identified in human breast cancer cells (MUC1 in humans and Muc1 in non-human species) (44) . MUC1 is normally expressed in secretory epithelial cells of the respiratory, gastrointestinal and female reproductive tracts as well as in lymphoid cells (6, 11, 15, 16, 21, 33, 36) and is highly overexpressed in most carcinomas (11, 12) including those of breast, ovary, pancreas, stomach, colon and lung. Tumors induced by polyoma virus middle T antigen in Muc1 null mice develop slower than in their wild type counter parts (45) . Furthermore, MUC1 has been shown to be capable of acting as an antiadhesion molecule (15, 19, 23 ) and may promote metastasis. While the function of MUC1 is not completely understood, it has been shown to be involved in acquired immunity, cell adhesion and maintenance of normal cellular function and development (11, 12, 19) . We have recently reported that MUC1 may act as a receptor for Pseudomonas aeruginosa (27) and furthermore, it has been reported that MUC1 is upregulated in cystic fibrosis cells (13) suggesting that MUC1 might play a role in the pathogenesis of cystic fibrosis.
Expression of MUC1 has been shown to be influenced by a number of factors including hormones and retinoids (5, 18, 20, 29, 33, 47) , cytokines (9, 10) , tyrosine kinase inhibitors (13, 50) and possibly by gene modifications such as DNA methylation or DNA conformational status (4, 31, 32, 52) . While the molecular mechanisms of the regulation of MUC1 transcription by these factors are not well defined, cis-acting elements within the MUC1 promoter mediating the effects have been identified. (1, 10, 24, 25, 43) . MUC1 promoter regions containing some of these elements have been cloned upstream of heterologous genes, and have been shown to be able to drive their expression when transfected into MUC1 expressing cancer cell lines. These gene constructs are being considered for possible targeting of genes to carcinomas for gene therapy 6 transcriptase (Superscript: Invitrogen, Carlsbad, CA) at 42 o C for 1 hr. Extension products were resolved on a 6%, 8M urea acrylamide gel.
Preparation of Muc1 promoter/luciferase constructs and luciferase assay
Promoter deletion/luciferase constructs were prepared by digesting pMuc1pro-pBS with
BspH1 and then treating with Klenow enzyme (New England Biolabs, Waverly, MA) to get blunt ends. Then the plasmid was digested with SacI and the fragment purified and cloned into the pGL2-Basic vector (Promega, Madison, WI) prepared as described below. The plasmid pGL2-Basic was digested with XhoI and then treated with Klenow enzyme to make blunt ends and then digested with SacI. The resulting construct was designated as pMuc1-2354-luc.
Subsequent deletion constructs were synthesized by digesting pMuc1-2354-luc with SacI and one of the following restriction enzymes: Sma I, Dra I, Nco I, Pst I, BstX I or Apa I and treatment with Mung bean nuclease and then religation and subsequent transfection into competent STBL cells (Invitrogen, Carlsbad, CA).
The Muc1 promoter/luciferase construct lacking the P-NRE was constructed as follows:
pMuc1-2354-luc was digested with NcoI and then treated with Mung bean nuclease. This plasmid was then digested with SacI and the large 7.8 kb fragment isolated. Another sample of pMuc1-2354-luc was digested with SacI and HindIII and the 2.4 Kb fragment isolated. This fragment was digested with DraI and the 699 bp fragment isolated. This fragment was ligated to the 7.8 kb fragment prepared as described above to get a plasmid identical to pMuc1-2354-luc with the exception of the absence of bases -1651 to -1615 and designated as pMuc1-2354∆P-NRE-luc.
To determine the effect of the P-NRE on transcription from a heterologous promoter, one or two copies of the P-NRE was cloned upstream of the SV40 promoter connected to a luciferase reporter gene. or the scrambled version: P-NRE-mut (sense strand): 5'-TAACAGCTGCATGGATGCTGTCACGACCGATTCAAGG-3' were allowed to anneal and ligated to each other to create multimers. The ligated oligonucleotides were purified and then annealed to pGL2-C prepared as described above. The plasmids were digested with HindIII and
KpnI to test for P-NRE or P-NRE-mut inserts. Clones containing inserts were sequenced to confirm proper sequence and orientation of the P-NRE and P-NRE-mut. The constructs synthesized as described above were transiently transfected into human and hamster cells using SuperFect (Qiagen, Valencia, CA) according to the manufacturer's protocol. Briefly, cells were incubated with a mixture of plasmid DNA and SuperFect for 3 hr at 37 o C in 5% CO 2 after which the transfection mixture was removed and replaced with media. The cells were grown for an additional 48 hrs and then lysed in Reporter Lysis Buffer (Promega, Madison, WI). Cells were scraped off and transferred to microcentrifuge tubes and subjected to three freeze-thaw cycles after which the tube was vortexed for 20 seconds and then centrifuged for 3 min at 13,200 RCF.
The supernatant was used to measure luciferase activity using luciferase assay system kits (Promega, Madison, WI).
Electrophoretic mobility shift assay
Nuclear extracts were prepared from HP-1 cells using a modification of the procedure of but not in CHO cells (Fig. 3A) , and it was active in all of the three human cells tested (Fig. 3B) .
Identification of the P-NRE as a YY-1 transcription factor binding site
Analysis of the DNA sequence of the P-NRE and the immediately surrounding areas indicated a potential YY1 binding site towards the 3' end of the P-NRE-37 mer (5'-CCATG-3').
To determine whether YY1 can bind to this region, an oligonucleotide spanning the 37 mer and an additional 10 bp downstream (designated P-NRE-47) was synthesized and labeled and used as a probe in EMSA experiments. Nuclear extract was prepared from hamster HP-1 cells. As 12) . Finally, an antibody made against YY1 and known to recognize both rodent and human YY1 was added to the band shift reaction and a "supershift" was clearly seen confirming that YY1 binds to the P-NRE region (lane 13).
To determine the effect of the removal of the P-NRE region in the context of the full length fold increase in transcription compared to the wild type pMuc1-2354-luc as well as deletion constructs containing the P-NRE (pMuc1-1698-luc and pMuc1-1651-luc). The level of transcription from the pMuc1-2354∆P-NRE-luc construct was similar to or slightly higher than the deletion construct lacking the P-NRE (Fig. 5 ). This result indicates that the region in between -1652 and -1614 normally represses transcription of the Muc1 gene in HP-1 cells and that the repression can be relieved by the removal of this site.
To determine whether the P-NRE is capable of repressing transcription from a heterologous promoter, the P-NRE was placed upstream of the SV40 promoter connected to the luciferase reporter gene and transfected into HP-1 cells. As can be seen in Fig. 6 , the presence of a single copy of the P-NRE in the correct orientation (same direction as in Muc1 promoter) upstream of the SV40 promoter resulted in a small decrease in transcription. However, when two copies of the P-NRE were attached in the correct orientation, a further decrease in transcription was seen.
Interestingly, when two copies of the P-NRE were cloned in the opposite orientation, the level of inhibition of transcription was higher than when two copies were placed in the correct orientation. Cloning a copy of a scrambled P-NRE sequence (P-NRE-mut) resulted in no significant change in transcription from the SV-40 promoter/reporter construct. These results indicate that the P-NRE is capable of inhibiting transcription from a heterologous promoter and in an orientation-independent manner. Furthermore, the repressive effect of P-NRE is additivethat is, two copies result in a greater level of inhibition of transcription than one copy.
DISCUSSION
The Because these two regions do not share sequence similarity, it is currently unclear whether they represent separate PREs or whether their differences in activity reflect differences in the cell types examined. A third study (24) identified two additional MUC1 regulatory elements (Sp1 and E-MUC1 binding sites) more proximal to the transcriptional initiation site relative to the two cis-acting elements described above. The authors of the study reported the importance of these two elements for the epithelial specific expression of MUC1. The 304 bp region containing a putative PRE in the promoter region of the hamster Muc1 gene reported here has a 68% identity to the corresponding region in the human MUC1 gene. Moreover, the three cis-acting elements described above are 100 % conserved between the human MUC1 and hamster Muc1 promoters suggesting that the positive regulatory mechanisms utilized to regulate the MUC1 and Muc1 genes are similar.
Our functional studies in HP-1 cells also identified a putative negative regulatory element promoter resulted in a two-fold increase in transcription, supporting the notion that the P-NRE can function to regulate the transcription of Muc1. Furthermore, our results demonstrate that the P-NRE can act as a transcriptional repressor in an orientation as well as distance (from the transcriptional initiation site) independent manner. Also, the P-NRE functions in an additive fashion -that is, two copies placed upstream of the SV40 promoter inhibited transcription to a greater extent than a single copy. The P-NRE is well conserved in the mice Muc1 promoter promoter is sufficient to confer epithelial-specific expression as well as induction during lactation and polyoma T protein induced tumorigenesis in transgenic mice (14) . The corresponding human MUC1 P-NRE site that we describe in this report is located upstream of the 1.4 kb region and thus, the P-NRE may be involved in the modulation of the correct MUC1/ Muc1 regulation during epithelial specific expression or induction during lactation or tumorigenesis. Alternatively, the putative function of the P-NRE in the transcriptional regulation of MUC1 may be compensated in the MUC1 transgenic mice by the presence of appropriate chromatin structure at the MUC1 gene integration site. It should be noted that only 2 out of 10 founder mice carrying the MUC1 promoter demonstrated correct tissue specific expression and induction during lactogenesis and tumorigenesis, and that the level of induction was relatively low (14) . It is also possible that the P-NRE is involved in the regulation of Muc1 gene expression during states not described above or in a species specific manner.
As seen in Fig. 4 , our detailed EMSA analysis clearly demonstrates that YY1 can bind to the Muc1 P-NRE. These results indicate that YY1 binds to the P-NRE and may have a repressive role in the transcription of the Muc1 gene although we cannot rule out that other factors which are undetectable by EMSA also bind to the P-NRE and affect the transcription of Muc1. YY1 is a C 2 H 2 zinc finger protein which is ubiquitously expressed and can act as both a transcriptional repressor and activator depending on the promoter context (48) . It has been shown to be involved in the repression of the β-casein gene in mammary epithelial cells (30). YY1 has been shown to be bound to Sp1 transcription factor (42) as well as both histone deacetylases (HDAC1 and HDAC2) and histone acetyltransferase (HAT) (48). Thus, it may possible that YY1
represses the activation of Muc1 transcription by interactions with Sp1 or HDAC1/2 or HAT.
Our computer searches indicate the presence of four other potential YY1 binding sites within the Muc1 promoter. It would be important to determine whether YY1 also binds to these sites and whether the binding of YY1 affects the transcriptional level from the Muc1 promoter.
In conclusion, the molecular mechanisms involved in the regulation of MUC1 transcription seem to be rather complex but the details are beginning to emerge. We report here a PRE in the hamster Muc1 promoter that seems homologous both in sequence and function to the PREs described in the human MUC1 gene promoter. A novel P-NRE located about 1.6 kb upstream from the transcriptional initiation site, which is a binding site for the YY1 transcription factor, seems to be important for the transcriptional regulation of the Muc1 gene based on the series of experiments described here. We are currently investigating the transcriptional regulation of the Muc1 gene based on the YY1 binding to the P-NRE site as well as other potential binding sites on the Muc1 promoter. One or two copies of the P-NRE was cloned upstream of the SV40 promoter connected to a lucife rase reporter gene, the resulting plasmid constructs transfected into HP-1 cells, and luciferase activity measured as described in Methods. "1M" represents one copy of a scrambled P-NRE (P-NRE-mut in the text). The "correct" orientation means the same direction as in Muc1 promoter whereas the "rev" represents the reverse direction. Note that the mutation of P-NRE resulted in a complete loss of the P-NRE activity whereas the presence of the intact P-NRE upstream of the SV40 promoter resulted in a significant inhibition of the promoter activity in a copy number dependent but orientation independent manner. * p<0.01 (compared with the 0 copy group) 
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